Associations between platelet monoamine oxidase-B activity and acquired colour vision loss in a fish-eating population

Neurotoxicology and Teratology

Volumn 28, Issue 4, 2006, Pages 446-452

  Stamler, Christopher John ^a   Mergler, Donna ^b   Abdelouahab, Nadia ^b   Vanier, Claire ^b   Chan, Hing Man ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

Cigarette smoking; Colour vision; Mercury; Monoamine oxidase; Surrogate biomarker

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; BIOCHEMICAL MARKER; DOPAMINE; MERCURY;

ADULT; ARTICLE; BODY BURDEN; BOWMAN COLOR CONFUSION INDEX; CANADA; COLOR DISCRIMINATION; COLOR VISION DEFECT; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC TEST; DISEASE MARKER; DOPAMINERGIC SYSTEM; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; FEMALE; FISH; FOOD CONTAMINATION; HUMAN; HUMAN CELL; LANTHONY D 15 DESATURATED PANEL TEST; MAJOR CLINICAL STUDY; MALE; MONOAMINERGIC SYSTEM; NEUROTOXICITY; POPULATION; PRIORITY JOURNAL; SMOKING; THROMBOCYTE; VISION TEST;

AGING; ANIMALS; BIOLOGICAL MARKERS; BLOOD PLATELETS; COLOR VISION DEFECTS; CROSS-SECTIONAL STUDIES; DIET; DISCRIMINATION (PSYCHOLOGY); FEMALE; FISHES; FUNCTIONAL LATERALITY; HUMANS; MALE; MEAT; MERCURY; MIDDLE AGED; MONOAMINE OXIDASE; RISK ASSESSMENT;

NICOTIANA TABACUM;

EID: 33748335510     PISSN: 08920362     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ntt.2006.05.004     Document Type: Article

References (57)

1. Ardouin M., Urvoy M., Raoul T., and Herve M.C. Electroretinographic study of a case of monoamine oxidase inhibitor poisoning. Bull. Soc. Ophtalmol. Fr. 67 (1967) 920-924
2. Bergamaschi E., Smargiassi A., Mutti A., Cavazzini S., Vettori M.V., Alinovi R., Franchini I., and Mergler D. Peripheral markers of catecholaminergic dysfunction and symptoms of neurotoxicity among styrene-exposed workers. Int. Arch. Occup. Environ. Health 69 (1997) 209-214
3. Berlin I., and Anthenelli R.M. Monoamine oxidases and tobacco smoking. Int. J. Neuropsychopharmacol. 4 (2001) 33-42
4. Berlin I., Said S., Spreux-Varoquaux O., Olivares R., Launay J.M., and Puech A.J. Monoamine oxidase A and B activities in heavy smokers. Biol. Psychiatry 38 (1995) 756-761
5. Beyrouty P., Stamler C.J., Lui J.N., Loua K.M., Kubow S., and Chan H.M. Effects of prenatal methylmercury exposure on brain monoamine oxidase activity and neurobehaviour in rats. Neurotoxicol. Teratol. 28 (2006) 251-259
6. Bowman K.J. A method for quantitative scoring of the Farnsworth Panel D-15. Acta Ophthalmol. (Copenh) 60 (1982) 907-916
7. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
8. Bridge T.P., Soldo B.J., Phelps B.H., Wise C.D., Francak M.J., and Wyatt R.J. Platelet monoamine oxidase activity: demographic characteristics contribute to enzyme activity variability. J. Gerontol. 40 (1985) 23-28
9. Buttner T., Kuhn W., Klotz P., Steinberg R., Voss L., Bulgaru D., and Przuntek H. Disturbance of colour perception in Parkinson's disease. J. Neural Transm., Parkinson's Dis. Dement. Sect. 6 (1993) 11-15
10. Buttner T., Kuhn W., Patzold T., and Przuntek H. l-Dopa improves colour vision in Parkinson's disease. J. Neural Transm., Parkinson's Dis. Dement. Sect. 7 (1994) 13-19
11. Campagna D., Stengel B., Mergler D., Limasset J.C., Diebold F., Michard D., and Huel G. Color vision and occupational toluene exposure. Neurotoxicol. Teratol. 23 (2001) 473-480
12. Castagnoli K., Steyn S.J., Magnin G., Van Der Schyf C.J., Fourie I., Khalil A., and Castagnoli Jr. N. Studies on the interactions of tobacco leaf and tobacco smoke constituents and monoamine oxidase. Neurotox. Res. 4 (2002) 151-160
13. Cavalleri A., and Gobba F. Reversible color vision loss in occupational exposure to metallic mercury. Environ. Res. 77 (1998) 173-177
14. Cavalleri A., Belotti L., Gobba F., Luzzana G., Rosa P., and Seghizzi P. Colour vision loss in workers exposed to elemental mercury vapour. Toxicol. Lett. 77 (1995) 351-356
15. Chakrabarti S.K., Loua K.M., Bai C., Durham H., and Panisset J.C. Modulation of monoamine oxidase activity in different brain regions and platelets following exposure of rats to methylmercury. Neurotoxicol. Teratol. 20 (1998) 161-168
16. Checkoway H., Costa L.G., Camp J., Coccini T., Daniell W.E., and Dills R.L. Peripheral markers of neurochemical function among workers exposed to styrene. Br. J. Ind. Med. 49 (1992) 560-565
17. Checkoway H., Echeverria D., Moon J.D., Heyer N., and Costa L.G. Platelet monoamine oxidase B activity in workers exposed to styrene. Int. Arch. Occup. Environ. Health 66 (1994) 359-362
18. Coccini T., Castoldi A.F., Gandini C., Randine G., Vittadini G., Baiardi P., and Manzo L. Platelet monoamine oxidase B activity as a state marker for alcoholism: trend over time during withdrawal and influence of smoking and gender. Alcohol Alcohol. 37 (2002) 566-572
19. Costa L.G., and Manzo L. Biochemical markers of neurotoxicity: research strategies and epidemiological applications. Toxicol. Lett. 77 (1995) 137-144
20. Damberg M., Garpenstrand H., Hallman J., and Oreland L. Genetic mechanisms of behavior-don't forget about the transcription factors. Mol. Psychiatry 6 (2001) 503-510
21. Djamgoz M.B., and Wagner H.J. Localization and function of dopamine in the adult vertebrate retina. Neurochem. Int. 20 (1992) 139-191
22. Djamgoz M.B., Hankins M.W., Hirano J., and Archer S.N. Neurobiology of retinal dopamine in relation to degenerative states of the tissue. Vis. Res. 37 (1997) 3509-3529
23. Erb C., Nicaeus T., Adler M., Isensee J., Zrenner E., and Thiel H.J. Colour vision disturbances in chronic smokers. Graefe Arch. Clin. Exp. Ophthalmol. 237 (1999) 377-380
24. Fowler J.S., Volkow N.D., Wang G.J., Pappas N., Logan J., MacGregor R., Alexoff D., Shea C., Schlyer D., Wolf A.P., Warner D., Zezulkova I., and Cilento R. Inhibition of monoamine oxidase B in the brains of smokers. Nature 379 (1996) 733-736
25. Fowler J.S., Volkow N.D., Wang G.J., Pappas N., Logan J., Shea C., Alexoff D., MacGregor R.R., Schlyer D.J., Zezulkova I., and Wolf A.P. Brain monoamine oxidase A inhibition in cigarette smokers. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 14065-14069
26. Fox D.A., and Boyes W.K. Toxic responses of the ocular and visual system. In: Klaassen C.D. (Ed). Casarett and Doull's Toxicology: The Basic Science of Poisons (2001), McGraw- Hill, Toronto 565-595
27. Geller A.M., and Hudnell H.K. Critical issues in the use and analysis of the Lanthony Desaturate Color Vision test. Neurotoxicol. Teratol. 19 (1997) 455-465
28. Gobba F., and Cavalleri A. Color vision impairment in workers exposed to neurotoxic chemicals. Neurotoxicology 24 (2003) 693-702
29. Hamada H., Saito T., and Torii J. A case of optico-neuropathy due to the treatment with monoamine oxidase inhibitor (safrazine). Rinsho Shinkeigaku 19 (1979) 379-387
30. Hart Jr. W.M. Acquired dyschromatopsias. Surv. Ophthalmol. 32 (1987) 10-31
31. Jaeger W. Acquired colour-vision-deficiencies caused by side-effects of pharmacotherapy. Klin. Monatsbl. Augenheilkd. 170 (1977) 453-460
32. Knoll J., and Magyar K. Some puzzling pharmacological effects of monoamine oxidase inhibitors. Adv. Biochem. Psychopharmacol. 5 (1972) 393-408
33. Krajl M. A rapid microfluorometric determination of monoamine oxidase. Biochem. Parmacol. 14 (1965) 1683-1685
34. Lanthony P. The desaturated panel D-15. Doc. Ophthalmol. 46 (1978) 185-189
35. Lebel J., Mergler D., Lucotte M., Amorim M., Dolbec J., Miranda D., Arantes G., Rheault I., and Pichet P. Evidence of early nervous system dysfunction in Amazonian populations exposed to low-levels of methylmercury. Neurotoxicology 17 (1996) 157-167
36. Magos T. Monoaminergic influence on the visual evoked potentials (VEP). In: Hashimoto I., and Kakigi R. (Eds). Recent Advances in Neurophysiology (1998), Elsevier Science, Amsterdam 455-465
37. Magos T. Correlation between platelet monoamine oxidase activity and the strength of a visual illusion. Vis. Res. 42 (2002) 2031-2035
38. Manzo L., Artigas F., Martinez E., Mutti A., Bergamaschi E., Nicotera P., Tonini M., Candura S.M., Ray D.E., and Costa L.G. Biochemical markers of neurotoxicity. A review of mechanistic studies and applications. Hum. Exp. Toxicol. 15 Suppl 1 (1996) S20-S35
39. Mergler D. Review of neurobehavioral deficits and river fish consumption from the Tapajos (Brazil) and St. Lawerence (Canada). Environ. Toxicol. Pharmacol. 12 (2002) 93-99
40. Mergler D., Blain L., Lemaire J., and Lalande F. Colour vision impairment and alcohol consumption. Neurotoxicol. Teratol. 10 (1988) 255-260
41. Mora-Ferrer C., and Neumeyer C. Reduction of red-green discrimination by dopamine D1 receptor antagonists and retinal dopamine depletion. Vis. Res. 36 (1996) 4035-4044
42. Morrison J.H., Foote S.L., Molliver M.E., Bloom F.E., and Lidov H.G. Noradrenergic and serotonergic fibers innervate complementary layers in monkey primary visual cortex: an immunohistochemical study. Proc. Natl. Acad. Sci. U. S. A. 79 (1982) 2401-2405
43. National Research Council. Toxicological effects of methylmercury (2000), National Academy Press, Washington, DC
44. Ofori S., Bretton C., Hof P., and Schorderet M. Investigation of dopamine content, synthesis, and release in the rabbit retina in vitro: I. Effects of dopamine precursors, reserpine, amphetamine, and l-DOPA decarboxylase and monoamine oxidase inhibitors. J. Neurochem. 47 (1986) 1199-1206
45. Oreland L. Monoamine oxidase in neuropsyciatric disorders. In: Vusahara H., Parvez S.H., Ogushi K., Sandler M., and Nagatsu T. (Eds). Monoamine Oxidase: Basic and Clinical Aspects (1993), VSP, Utrecht 219-247
46. Price M.J., Feldman R.G., Adelberg D., and Kayne H. Abnormalities in color vision and contrast sensitivity in Parkinson's disease. Neurology 42 (1992) 887-890
47. Rodnitzky R.L. Visual dysfunction in Parkinson's disease. Clin. Neurosci. 5 (1998) 102-106
48. Rommelspacher H., May T., Dufeu P., and Schmidt L.G. Longitudinal observations of monoamine oxidase B in alcoholics: differentiation of marker characteristics. Alcohol. Clin. Exp. Res. 18 (1994) 1322-1329
49. Shih J.C., Chen K., and Ridd M.J. Monoamine oxidase: from genes to behavior. Annu. Rev. Neurosci. 22 (1999) 197-217
50. Smargiassi A., Mergler D., Bergamaschi E., Vettori M.V., Lucchini R., and Apostoli P. Peripheral markers of catecholamine metabolism among workers occupationally exposed to manganese (Mn). Toxicol. Lett. 77 (1995) 329-333
51. Stamler C.J., Basu N., and Chan H.M. Biochemical markers of neurotoxicity in wildlife and human populations: considerations for method development. J. Toxicol. Environ. Health A 68 (2005) 1413-1429
52. Stamler C.J., Abdelouahab N., Vanier C., Mergler D., and Chan H.M. Relationship between platelet monoamine oxidase-B (MAO-B) activity and mercury exposure in fish consumers from the Lake St. Pierre region of Quebec, Canada. Neurotoxicology 27 (2006) 429-436
53. Takeuchi T., and Eto K. The Pathology of Minimata Disease (1999), Kyushu University Press, Hakozaki, Japan
54. Thorpe L.W., Westlund K.N., Kochersperger L.M., Abell C.W., and Denney R.M. Immunocytochemical localization of monoamine oxidases A and B in human peripheral tissues and brain. J. Histochem. Cytochem. 35 (1987) 23-32
55. Urban P., Gobba F., Nerudova J., Lukas E., Cabelkova Z., and Cikrt M. Color discrimination impairment in workers exposed to mercury vapor. Neurotoxicology 24 (2003) 711-716
56. Verriest G. Further studies on acquired deficiency of color discrimination. J. Opt. Soc. Am. 53 (1963) 185-195
57. Verriest G. Acquired color perception defects. Mem. Acad. R. Med. Belg. 18 (1964) 35-327